login
login

Europe Daily Bulletin No. 8691

23 April 2004
Contents Publication in full By article 43 / 44
GENERAL NEWS / (eu) eu/health

22/04/2004 (Agence Europe) - The European Commission has chosen the consulting company for assisting in the decision applied to life sciences and chemistry ALCIMED for carrying out a study on the issue of orphan medicine prices. This study aims to assess the system for determining medicine prices, as well as defining tools for evaluating if prices are reasonable, for the point of view of patients, business leaders and Member States. (Info: c.flin@hbcommunication.fr).

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS